Chemoinformaics analysis of dodeca-2-trans-4-cis-8,10-diynoic acid isobutylamide
Molecular Weight | 494.764 | nRot | 16 |
Heavy Atom Molecular Weight | 444.364 | nRig | 5 |
Exact Molecular Weight | 494.387 | nRing | 0 |
Solubility: LogS | -3.12 | nHRing | 0 |
Solubility: LogP | 3.603 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 86 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 32 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 90.5836 |
nHD | 2 | BPOL | 53.0364 |
QED | 0.65 |
Synth | 3.13 |
Natural Product Likeliness | 0.894 |
NR-PPAR-gamma | 0.01 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.18 |
Pgp-sub | 0.004 |
HIA | 0.004 |
CACO-2 | -4.594 |
MDCK | 0.0000218 |
BBB | 0.506 |
PPB | 0.953523 |
VDSS | 0.88 |
FU | 0.0358618 |
CYP1A2-inh | 0.334 |
CYP1A2-sub | 0.142 |
CYP2c19-inh | 0.346 |
CYP2c19-sub | 0.689 |
CYP2c9-inh | 0.39 |
CYP2c9-sub | 0.506 |
CYP2d6-inh | 0.042 |
CYP2d6-sub | 0.833 |
CYP3a4-inh | 0.185 |
CYP3a4-sub | 0.241 |
CL | 7.261 |
T12 | 0.785 |
hERG | 0.274 |
Ames | 0.348 |
ROA | 0.817 |
SkinSen | 0.985 |
Carcinogencity | 0.42 |
EI | 0.458 |
Respiratory | 0.968 |
NR-Aromatase | 0.134 |
Antiviral | No |
Prediction | 0.560647 |